dc.creatorSiqueira, Marilda Agudo Mendonça Teixeira de
dc.creatorMúltipla autoria - ver em Notas
dc.date2018-07-03T17:16:08Z
dc.date2018-07-03T17:16:08Z
dc.date2014
dc.date.accessioned2023-09-26T21:01:06Z
dc.date.available2023-09-26T21:01:06Z
dc.identifierMUTHURI, Stella G. et al. Effectiviness of Neuraminidase inhibitors in reducing mortality in hospitalised Influenza A (H1N1)pdm09 patientss: an individual participant data meta-analysis. The Lancet Respiratory Medicine, v.2, n.5, p.395-404, May 2014.
dc.identifier2213-2600
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/27247
dc.identifier10.1016/S2213-2600(14)70041-4
dc.identifier2213-2619
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8867801
dc.descriptionFront author affiliations can be found on pp 25-29 †List of PRIDE Consortium Investigators’ can be found on pages 20, and affiliations listed in appendix pp 1-6
dc.descriptionNeuraminidase inhibitors were widely used during the 2009–10 influenza A H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We did a meta-analysis of individual participant data to investigate the association between use of neuraminidase inhibitors and mortality in patients admitted to hospital with pandemic influenza A H1N1pdm09 virus infection.
dc.description2030-01-01
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsrestricted access
dc.subjectEfetividade
dc.subjectinibidores da neuraminidase
dc.subjectRedução de mortalidade
dc.subjectPacientes hospitalizados
dc.subjectgripe A H1N1
dc.subjectinfecção viral
dc.subjectEffectiveness
dc.subjectneuraminidase inhibitors
dc.subjectreducing mortality
dc.subjecthospital
dc.subjectinfluenza A H1N1
dc.subjectvirus infectio
dc.titleEffectiviness of neuraminidase inhibitors in reducing mortality in hospitalized influenza A (H1N1)pdm09 patients: an individual participant data meta-analysys
dc.typeArticle


Este ítem pertenece a la siguiente institución